Immunotherapy Advances in Small Cell Lung Cancer

Cancerresearch

Small cell lung cancer (SCLC) is aggressive and often difficult to treat, but many patients may have new hope. On August 17, 2018, the FDA approved the first immunotherapy the checkpoint inhibitor nivolumab (Opdivo, Bristol-Myers Squibb for patients with small cell lung cancer. Since this approval, there has been renewed focus on how to make different immunotherapies work for a disease which typicallly comprises 10-15% of all lung cancer cases. In this webinar for patients and caregivers, Matthew Hellmann, M.D., of Memorial Sloan Kettering Cancer Center discusses the new FDA approval, clinical trials, and potential treatments for patients with small cell lung cancer.
Watch Now

Spotlight

Hospital groups facing stiff competition from smaller, more nimble independent practices can benefit greatly from SocialClimb.

OTHER ON-DEMAND WEBINARS

Snowflake’s 2023 Outlook for Healthcare and Life Sciences Trends

Today’s rapid acceleration of data in healthcare and life sciences requires a comprehensive strategy to enable organizations to harness the value of data in order to improve health outcomes.
Watch Now

IASLC Educational Webinars

Iaslc

IASLC webinars bring the most contemporary trends and latest developments in the lung cancer directly to you. The webinars produced by the IASLC provide in-depth coverage on a diverse array of topics related to the prevention, detection, diagnosis, treatment of lung cancer and other thoracic malignancies each complete with a question and answer session that allows you to interact directly with experts in the field.
Watch Now

Occupational Safety and Health under EPA-TSCA

OSHA standards are the backbone of EPA’s extensive requirements for protection of workers under the Toxic Substances Control Act, but EPA adapts them under TSCA.
Watch Now

5th Annual ComplianceOnline Medical Device Summit 2020

This Summit will feature speakers and executives from FDA/CDRH, Ex-FDA Officials and companies like Merck, BSI, Novartis Institutes for BioMedical Research (NIBR), Orchard Therapeutics, Owl Cyber Defense and several other leading organizations. Why should attend his summit: Future Trends of Medical Device Regulation, Risk Manage
Watch Now